Why is Bharat Immunolog falling/rising?

As of 24-Sep, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 21.54, down by 0.05 or 0.23%. The stock has been losing value for the last three days, with a total decline of 1.96% during this period. It is trading below all its moving averages, indicating a bearish trend. The company has not declared results in the last six months, which raises concerns about its long-term fundamental strength. Additionally, the net sales have decreased significantly by 87.03% in the latest reporting period, and the operating cash flow is at its lowest. The high debt-to-equity ratio and consistent underperformance against benchmarks further contribute to the stock's weak outlook.
In the broader market context, Bharat Immunological's performance over the past week shows a decline of 2.09%, while the Sensex has only fallen by 1.18%. This indicates that the stock is underperforming relative to the market. Over the past year, the stock has generated a return of -24.29%, significantly worse than the Sensex's decline of 3.77%. The company's poor long-term growth metrics and inability to service debt effectively suggest a challenging environment, making it a risky investment compared to its historical valuations.